Hypogammaglobulinaemia during rituximab treatment in multiple sclerosis: A Swedish cohort study
{{output}}
Background and purpose: Mechanisms behind hypogammaglobulinaemia during rituximab treatment are poorly understood. Methods: In this register-ba... ...